Veriheal

AUGUST 22, 2022

Clinical trials into cannabis’ potential as an opioid replacement are well underway in South Africa. Quite frankly, the clinical trials couldn’t have come at a better time. About the Opioid Epidemic. This process involves feeding the nutrient-dense aquaculture water to hydroponically cultivated plants.

Clinical Trials

The Cannigma

MARCH 7, 2022

CBN’s ability to target CB2 receptors, in comparison to THC (which prefers the CB1 receptor), gives it better credibility in treating autoimmune conditions such as rheumatoid arthritis, multiple sclerosis, and inflammatory bowel disease. What can the current clinical trials tell us?

THC

Veriheal

JUNE 29, 2022

While 233 participants might sound low, it is still the largest number of humans to participate in a psilocybin-based clinical trial. It’s rare to see such positive outcomes of clinical trials in this disease area, which is why these results are so significant. Food and Drug Administration (FDA) for the treatment of TRD.

Clinical Trials

The Blunt Truth

DECEMBER 23, 2020

These companies faced administrative actions by the FTC for “making a wide range of scientifically unsupported claims about their ability to treat serious health conditions,” such as cancer, Alzheimer’s disease, and pain relief. The warning letters address the illegal marketing of unapproved CBD products claiming to treat medical conditions.

CBD

Project CBD

NOVEMBER 11, 2023

And then cannabis has unique effects for a wide range of conditions, everything from the treatment of pain, treatment of asthma, treatment of immune conditions. There’s a condition that we call GERD, gastroesophageal reflux disease. You can make wonderful foods from them. Dr. Weil: Yes, it does.

Medicine

Cannabis Law Report

AUGUST 14, 2021

Cann Group CEO Peter Crock said of the products: “Satipharm CBD capsules were one of the first medicinal cannabis products available to approved patients in Australia (under the Special Access Scheme) and have been successfully used in a variety of medical conditions since 2017.

CBD

Cannabis Law Report

AUGUST 3, 2021

Food and Drug Administration, Health Canada or other similar regulatory authorities have not evaluated claims regarding psilocybin, psychedelic tryptamine, tryptamine derivatives or other psychedelic compounds or nutraceutical products. Vigorous scientific research and clinical trials are needed.

Clinical Trials

Cannabis Law Report

DECEMBER 2, 2021

(IGC) is excited to present preliminary positive secondary end point findings from its Phase 1 clinical trial for IGC-AD1. The results of the clinical trial have been submitted in the Clinical/Statistical Report (“CSR”) filed with the FDA, and relevant data is also available on Form 8-K filed with the SEC on December 2, 2021.

Clinical Trials

Project CBD

FEBRUARY 28, 2023

Under section 201(ff)(3)(B) of the Federal Food, Drug, and Cosmetic Act — in what some refer to as the “drug preclusion clause” 4 — any substance that is an active ingredient in an approved drug product, or that is being publicly investigated as such, is excluded from the definition of a legal dietary supplement ingredient. 2021;56:530-543.

CBD

Cannabis Law Report

AUGUST 19, 2021

Britain’s Food Standards Agency now regulates the sector and its marketing, after the European Union classified CBD as food in 2019. Faced with booming sales, professor Sagnik Bhattacharyya, who researches psychotic and substance abuse disorders at King’s College London, says clinical trials are needed.

Cannabinoids

Veriheal

OCTOBER 13, 2020

Ulcerative Colitis is a condition that causes long-lasting inflammation and ulcers (sores) in the innermost lining of the individual’s large intestine and rectum. Crohn’s Disease is also a condition that causes inflammation, but it affects the lining of the digestive tract, which can then spread deeply into the affected tissues. .

Digestion

Cannabis Law Report

OCTOBER 6, 2021

Flora Pharma’s objective is to create and leverage a proprietary drug development platform in collaboration with an artificial intelligence and machine learning group to identify new bioactive compounds within the cannabis plant that interact with certain gene targets responsible for specific disease states and conditions.

Clinical Trials

Kind Meds (Cannabis Education Blog)

NOVEMBER 18, 2020

It seems like the medical research community remains largely divided on the issue, with some insisting that cannabis use contributes to mental health condition diagnoses while others suggesting that people with mental health conditions are inherently drawn to cannabis use.

Treatment

Cannabis Law Report

AUGUST 17, 2021

Phase 3 planning for TrustTSC trial ongoing with first patient expected to be enrolled in Q4 2021. Food and Drug Administration (FDA) has granted orphan drug designation to ganaxolone in TSC. The condition is caused by inherited mutations in either the TSC1 gene or the TSC2 gene. RADNOR, Pa.–(BUSINESS

Pharmaceutical

Cannabis Law Report

JULY 29, 2021

Food and Drug Administration for Generally Recognized as Safe (GRAS) is being pursued. GRAS status will allow for the broad application of this novel ingredient in foods as well as dietary supplements. PCT/CA2021/050886, with a filing date of June 28, 2021. Through the Tetra partnership with Thorne HealthTech, a submission to the U.S.

Research and Development

Cannabis Law Report

AUGUST 6, 2021

Clinical trials have shown that small doses of CBD help people to manage their social anxiety. You shouldn’t ever self-medicate with CBD, especially if you suffer from a longstanding chronic condition. CBD is believed to stimulate the production of serotonin, your brain’s feel-good chemical. Thanks for reading.

CBD

MMJ Recs

JULY 9, 2024

Living with chronic conditions such as Multiple Sclerosis (MS) is profoundly challenging and impacts various aspects of daily life. of medical marijuana as a viable treatment option for certain conditions, including Multiple Sclerosis (MS), leading to increased advocacy for uniform regulations and broader accessibility.

Marijuana

Veriheal

JUNE 29, 2021

In order to legally access other therapies including nature-based options such as psilocybin , you must gain access under a Right to Try law which requires you to have a terminal condition. Introducing the Right to Try Act. The FDA refers to this program as the expanded access program on their website.

Therapy

Cannabis Law Report

SEPTEMBER 1, 2021

The company recently became the industry’s first firm to list on the NYSE American exchange and their psilocybin clinical trial for depression is making excellent progress. Going public in November 2020 on the NEO exchange, the firm has been steadily growing its market cap and development pipeline. Diversified Drug Development.

Research and Development

Veriheal

MAY 25, 2023

Regardless of which road you go down to treat mental health disorders or another type of medical condition, it’s imperative that you consult with a healthcare professional beforehand. ” When used recreationally as a party drug, ketamine is normally snorted in the form of a crystallized powder.

Medicine

United Patients Group

JANUARY 5, 2023

They can be found in certain foods and supplements, including yogurt, kefir and kombucha. Probiotics also occur naturally in fermented foods such as sauerkraut and pickles. They also reduce inflammation in the body and fight off viruses and harmful germs that may enter through food or water. What are Probiotics?

Digestion

Canna Care Docs

OCTOBER 3, 2023

” In this clinical trial, the efficacy of a synthetic THC compound (dronabinol) was found to improve appetite and weight gain in patients experiencing lack of appetite. CannaCare extends our compassion to anyone undergoing care for a terminal condition and would like to provide assistance in any manner that we can.

Chronic Pain

LifeCannMD

FEBRUARY 27, 2024

Medical Marijuana exhibits neuroprotective properties, meaning it can protect nerve cells against damage, degeneration, or impairment of function in conditions like epilepsy, where excessive neuronal activity can lead to damage. CBD’s ability to reduce glutamate levels and enhance GABA activity can help to reduce seizures.

Clinical Trials

Canna Law Blog

MARCH 4, 2020

Similar to ketamine, psilocybin has shown great promise in clinical trials for helping to effectively treat depression and PTSD (and we’ve written about psilocybin several times on this blog, including here and here ). Food and Drug Administration (FDA) to cities and counties.

Legalization

Cannabis Law Report

JUNE 24, 2022

Full story at.

Clinical Trials

Greencamp

FEBRUARY 17, 2019

Usually, the diagnosis involves excluding conditions like parasitic infections, lactose intolerance tests and small intestinal bacterial overgrowth which all produce symptoms like IBS. Constant gut symptoms often lead to the development of other conditions like anxiety , depression , migraines , sleeping problems and fatigue.

Digestion

Cannabis Law Report

FEBRUARY 24, 2022

Subsection 56(1) of the CDSA will exempt medical providers from enforcement of the CDSA when providing psilocybin and MDMA treatment to patients suffering serious or terminal health conditions. Publications from Health Canada stress that clinical trials are still the best avenue to access drugs like psilocybin and MDMA.

Therapy

The Cannigma

JUNE 15, 2021

More and more CBD products on the market promise relief from pain, depression, anxiety, neurodegenerative conditions, and a plethora of other symptoms and conditions. Amy Abernethy clarified that CBD products may not be marketed as food or food supplements. Easy access. CBD’s interaction with benzodiazepines.

CBD

Veriheal

APRIL 11, 2022

Food and Drug Administration (FDA) when offered in pill form to cancer chemotherapy patients, as well as people who endure appetite loss and/or wasting syndrome caused by AIDS. Additionally, numerous other cannabis-based medications have already gained approval or are in the process of being tested in clinical trials.

Pharmaceutical

Cannabis Law Report

NOVEMBER 19, 2021

“These additional patent filings are key as PsyBio moves towards the initiation of appropriately approved safety and efficacy clinical trials for our selected compounds within the production and manufacturing arena, for the Company as well as for our investors.” Vigorous scientific research and clinical trials are needed.

Clinical Trials

Cannabis Law Report

JULY 9, 2021

The Horizons ETFs product family includes a broadly diversified range of solutions for investors of all experience levels to meet their investment objectives in a variety of market conditions. Horizons ETFs has over $19 billion of assets under management and 95 ETFs listed on major Canadian stock exchanges.

Data

Cannabis Law Report

MAY 31, 2022

The only psychedelic drug that is approved (outside of clinical trials) for psychiatric use—as opposed to anesthesia—through the traditional medical system is Ketamine. Food and Drug Administration (FDA) approved esketamine (a component of Ketamine and sold under the brand name Spravato) for treatment-resistant depression.

Clinical Trials

Cannabis Law Report

APRIL 21, 2022

The availability of larger quantities of cGMP-compliant MDMA will facilitate ongoing clinical trials and provide for future therapeutic use following anticipated regulatory approvals. in each of the four validation trials with an acceptable yield, which is a noteworthy accomplishment.

Clinical Trials

Cannabis Law Report

MAY 28, 2022

The firm represents clients around the world in major industries including energy and natural resources; financial services and capital markets; food and agribusiness; healthcare, life sciences and education; real estate, development and construction; and technology, manufacturing and transportation. How did this come to fruition?

Research and Development

Cannabis Law Report

OCTOBER 13, 2021

Continued innovation, as demonstrated by our expanding IP portfolio, positions Cybin as a leading innovator in the development of putative psychedelic treatments for a variety of mental health conditions,” said Doug Drysdale, the company’s CEO. Vigorous scientific research and clinical trials are needed. About Cybin.

Clinical Trials

Cannabis Law Report

JULY 4, 2021

Clinical trials across the EU have also shown CBD oils and other hemp products to have a potential range of benefits. Today, people use CBD products to help with various medical conditions, such as diabetes, Chron’s disease, multiple sclerosis, and arthritis. With CBD, though, the “high” feeling is not created.

THC

Cannabis Law Report

JULY 7, 2021

Eurofins is a global leader in food, environment, and pharmaceutical product testing. It is also one of the market leaders in testing and laboratory services for genomics, discovery pharmacology, forensics, advanced material sciences and has a rapidly developing presence in highly specialised and molecular clinical diagnostic testing.

Pharmaceutical